Transmucosal administration of drug compositions for treating and preventing disorders in animals

Details for Australian Patent Application No. 2006214166 (hide)

Owner Novadel Pharma, Inc. Velcera Pharmaceuticals, Inc

Inventors Petrick, David; Steadman, Dennis; Benitz, Antonio; Heit, Mark

Agent Allens Arthur Robinson

Pub. Number AU-B-2006214166

PCT Pub. Number WO2006/089082

Priority 60/661,920 16.03.05 US; 60/669,888 11.04.05 US; 60/693,942 27.06.05 US; 60/664,939 25.03.05 US; 60/664,938 25.03.05 US; 60/665,525 28.03.05 US; 60/653,964 17.02.05 US; 60/664,183 23.03.05 US; 60/664,181 23.03.05 US; 60/670,651 13.04.05 US

Filing date 17 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 29 September 2011

International Classifications

A01N 25/00 (2006.01) Biocides

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089082 Priority application(s): WO2006/089082

29 September 2011 Application Accepted

  Published as AU-B-2006214166

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214169-Percutaneous spinal implants and methods

2006214164-Isoxazole combretastin derivatives for the treatment of disorders